Net profit of Sanofi India declined 45.99% to Rs 82.20 crore in the quarter ended September 2024 as against Rs 152.20 crore during the previous quarter ended September 2023. Sales rose 6.79% to Rs 524.00 crore in the quarter ended September 2024 as against Rs 490.70 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales524.00490.70 7 OPM %22.8423.13 - PBDT121.60123.80 -2 PBT112.60114.60 -2 NP82.20152.20 -46 Powered by Capital Market - Live News

Sanofi India will hold a meeting of the Board of Directors of the Company on 7 November 2024.Powered by Capital Market - Live News

Net profit of Sanofi India declined 15.87% to Rs 103.40 crore in the quarter ended June 2024 as against Rs 122.90 crore during the previous quarter ended June 2023. Sales declined 9.98% to Rs 463.50 crore in the quarter ended June 2024 as against Rs 514.90 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales463.50514.90 -10 OPM %24.9623.62 - PBDT120.10136.40 -12 PBT111.10127.30 -13 NP103.40122.90 -16 Powered by Capital Market - Live News

Sanofi India will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live News

Net profit of Sanofi India declined 28.26% to Rs 136.60 crore in the quarter ended March 2024 as against Rs 190.40 crore during the previous quarter ended March 2023. Sales declined 0.56% to Rs 732.40 crore in the quarter ended March 2024 as against Rs 736.50 crore during the previous quarter ended March 2023. ParticularsQuarter Ended�Mar. 2024Mar. 2023% Var. Sales732.40736.50 -1 OPM %29.8931.22 - PBDT225.10255.40 -12 PBT215.10245.70 -12 NP136.60190.40 -28 Powered by Capital Market - Live News